Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
|Articles|May 4, 2011

Prix Galien Sponsorship 2011

Advertisement
External Link - article-719040.pdf

Advertisement

Related Content

Advertisement
Adam Bartley

Why Integrated GMP Operating Models Are Reshaping Outsourced Manufacturing

ByAdam Bartley
August 25th 2026
Ying Huang

The Path from Discovery to Global Commercialization

ByMike Hollan,Ying Huang, PhD
August 25th 2026
Pharmaceutical Executive daily

Pharmaceutical Executive Daily: Hanmi Licenses HM17321 to Genentech

ByNicholas Jacobus
August 24th 2026
stock.adobe.com weight loss treatment

Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321

ByNicholas Jacobus
August 24th 2026
Ivo Carre

Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline

ByIvo Carre
August 24th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline

2

What the Peptide Advisory Vote Actually Means: Q&A with James LaValle

3

Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321

4

Focusing on Asset Acquisition Over Building a Single Platform Technology

5

Pharmaceutical Executive Daily: Hanmi Licenses HM17321 to Genentech

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us